Mobilise App Lab IPO Review: A 20% Discount Listing, a Crash to Rs 45, and a Rally to Rs 126 With No Clear Catalyst

Quick Answer

Mobilise App Lab, a small Faridabad based B2B SaaS company, had one of the more volatile post-listing journeys among the IPOs reviewed on this site. It listed on 2 March 2026 at Rs 64.10, nearly a 20% discount to its Rs 80 issue price, despite a positive grey market premium beforehand. From there it fell further, bottoming near Rs 45, before an unexplained rally carried it all the way to Rs 125.90 by early June. It's since settled back to around Rs 95 today, still meaningfully above the original issue price, but the round trip in between doesn't line up cleanly with anything in the company's actual, fairly modest financial results.

Key Details at a Glance

What Does Mobilise App Lab Ltd Do?

Picture a school administrator logging student attendance and fees through one screen, or a facilities manager tracking maintenance work orders across a hospital campus through another. Both of those are the kind of enterprise software Mobilise App Lab builds. You can track its live price alongside other IPO GMP data on the IPO GMP Live homepage.

Originally set up in 2013 and based out of Faridabad and Gurgaon, the company runs a B2B, subscription-based SaaS model with four core products: EDUPro, an ERP platform for educational institutions; OpsSuite, a computerised maintenance management system used in healthcare, food and beverage, and facility management settings; SCMPro, for supply chain and procurement; and HRevO, its HR and employee lifecycle management platform, reportedly its single biggest revenue contributor, priced on a mix of per-employee, per-month licensing and larger enterprise contracts. This is a genuinely small company by revenue, in the mid-teens of crores annually, operating in a competitive enterprise software space against much larger players.

How Strong Are the Financials?

Growth here has been positive but modest in absolute scale. Revenue moved from Rs 12 crore in FY24 to Rs 16 crore in FY25, with profit rising from Rs 3.10 crore to Rs 4.71 crore over the same period. The nine months to December 2025 showed Rs 14 crore in revenue and Rs 4.01 crore in profit, broadly consistent with continued growth, though one tracker separately noted a roughly 23% decline in net profit in the company's most recently reported period versus the one before it at the time, worth confirming against the company's own quarterly filings rather than treating as definitive here. Either way, this remains a business generating single-digit crores of quarterly profit, a genuinely small operation relative to the scale of price swings its stock has seen since listing.

Why Did the Stock Crash, Then Rally So Hard, With No Clear Explanation?

This is the part of the story that deserves the most honest treatment. The listing itself undershooting a positive GMP by landing at a nearly 20% discount was already a rough start. What happened over the following weeks made it worse, the stock continued falling to a 52-week low around Rs 45, a decline of roughly 44% from the original issue price.

Then, without a specific news catalyst turning up in this research, no major order win, contract announcement, or analyst upgrade, the stock staged a dramatic recovery, climbing steadily through April and May to touch a 52-week high of Rs 125.90 by early June, more than 2.5 times its March low and about 57% above the original issue price. It's since pulled back to settle around Rs 95 today. For a company this small, with a market capitalisation in the Rs 76 to 90 crore range and annual revenue in the teens of crores, this kind of swing is a useful illustration of how thin trading float and low liquidity can drive SME stock prices well beyond what any specific piece of company news would justify, in either direction. Readers should treat both the crash to Rs 45 and the rally to Rs 125.90 with real skepticism about whether either level reflected the underlying business at the time, rather than assuming either move was fundamentals-driven.

Should You Buy Mobilise App Lab at Current Levels?

Conservative investors: A stock that's fallen 44% below issue price and then rallied 57% above it within a four-month window, without a clear explanation for either move, is about as clear a signal of high volatility and thin liquidity as you'll find among recently listed SME names. This isn't a stock suited to investors who need price stability or predictable behaviour.

Moderate investors: If you hold from allotment, you're likely sitting on a gain from issue price even after the pullback from the June peak, worth deciding deliberately whether the underlying, genuinely small SaaS business justifies holding at current levels, or whether the recent volatility is reason enough to lock in gains.

Aggressive investors: A recurring-revenue SaaS model across education, healthcare, and HR software is a reasonable business to be in if execution continues, and the swings this stock has already shown suggest there's real trading volatility to work with either direction. But with no specific news found to explain the biggest move so far, betting on a repeat of the March-to-June rally is closer to speculation on SME liquidity dynamics than a fundamentals-based call.

Honest take. Mobilise App Lab is a small, real SaaS business whose stock price has moved far more dramatically than its underlying financial results over its first several months as a listed company, and this research couldn't find a specific catalyst that explains the scale of either the crash to Rs 45 or the rally to Rs 125.90. No named-analyst review was found for this IPO either, which is itself worth noting, there's less independent third-party scrutiny on record here than for several other companies reviewed on this site. My honest read is that at the current price, you're paying for a business that's grown steadily but modestly, and the stock's own recent history is the clearest available warning about how much this particular name can move without an obvious reason, worth sizing any position with that specifically in mind.

Where Did the IPO Money Go?

This was a 100% fresh issue. The largest single allocation, Rs 5.54 crore, was earmarked for product development through talent hiring, including a CTO, product heads, and AI/ML specialists. Rs 5.47 crore was allocated to company infrastructure, and Rs 3.03 crore toward business development and marketing to support domestic expansion. The remainder covered general corporate purposes and issue expenses. This is a reasonably clean, growth-directed allocation for a small software company, essentially funding people and go-to-market capability rather than debt repayment or asset purchases.

Contact Details

Company: Mobilise App Lab Ltd.

Location: Faridabad and Gurgaon, Haryana

Business: B2B SaaS enterprise software, including ERP for education (EDUPro), computerised maintenance management (OpsSuite), supply chain management (SCMPro), and HR/employee lifecycle management (HRevO)

Registrar: Bigshare Services Pvt. Ltd.

Lead Manager: Corporate Capital Ventures Pvt. Ltd.

Listing: NSE, SME platform

This page is not investment advice. GMP is indicative only and unofficial, and this IPO's own history, a discount listing despite positive GMP, followed by an unexplained multi-month rally, is a useful reminder of how little GMP and even recent price action can tell you about a small, thinly traded stock. Please consult a SEBI registered financial advisor before investing.